We found that each of these compounds showed comparable cytotoxicity in MCF-7 (ER positive and p53 wild-type) and MDA-MB-231 (triple negative and p53 mutant) breast cancer cell lines (Figure 1B). This evidence concerns the gene TP53 and breast carcinoma.